Delivery Order SPE2DB22D2006-SPE2DB25FW3KV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in a quantity of 1,000 units, valued at $1,565.14. This contract utilizes firm fixed pricing and carries an ultimate completion date of July 11, 2025. The award represents a non-set-aside, competitively awarded delivery order with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,402.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The order is scheduled for ultimate completion by June 20, 2025, and will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract value of $1,085.95. This competitively awarded, non-set-aside delivery order carries a firm fixed price and an ultimate completion date of May 7, 2025. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $1,599.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Doxycycline Hyclate 100 mg, with a completion deadline of August 20, 2025. This non-set-aside competitive award was issued on August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Doxycycline Hyclate 100 mg, valued at $1,121.97, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with no set-aside designation. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Doxycycline Hyclate, an antibiotic medication. This firm fixed-price delivery order, valued at $4,243.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and extends through December 2026. The delivery order carries no...
- The Defense Logistics Agency awarded a delivery order valued at $1,126.63 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This contract, issued on May 19, 2025, with an ultimate completion date of May 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award falls under the company's...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a ceiling value of $3,906.59 and a completion date of September 23, 2025. This non-set-aside contract reflects a firm fixed price arrangement for pharmaceutical delivery to support federal medical supply needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Doxycycline Hydrochloride 200 mg tablets in a 60-count package. This firm fixed-price delivery order, valued at $9,367.44, is scheduled for completion by July 10, 2025, and represents a non-set-aside competitive award. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3KVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,488.09. This firm fixed price delivery order is non-set-aside and represents a straightforward pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor for the Defense Logistics Agency's Medical Supply Chain, supplying a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. As a prime contractor under the DLA's pharmaceutical support framework, the company fulfills diverse medical procurement requirements across multiple therapeutic domains through competitively awarded contracts. This specific delivery order for doxycycline hyclate, a broad-spectrum antibiotic commonly used in military and federal healthcare settings, exemplifies the routine pharmaceutical deliveries executed under the larger IDC vehicle that enables flexible, global pharmaceutical support for defense health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/13/25 |